Skip to content

The Effect of Non-invasive Brian Stimulation on Language Production in Healthy Older Adults

The Effect of Transcranial Direct-current Stimulation on Discourse Production in Healthy Older Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04260815
Enrollment
14
Registered
2020-02-07
Start date
2018-10-02
Completion date
2019-08-22
Last updated
2020-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphasia, Language Disorders, Stroke

Brief summary

The use of non-invasive brain stimulation techniques like transcranial direct-current stimulation (tDCS) for rehabilitation of language is a growing field that needs further studies to determine how best it can be used to enhance treatment outcomes. It has been shown that tDCS can improve language performance in healthy and brain-injured individuals such as increased naming accuracy. However, at present, it is not known what effect tDCS has on higher-level language skills like discourse production (i.e. story telling, giving instructions) in healthy, older speakers. Therefore, the aim of this study is to investigate in healthy older adults, the effect of tDCS on discourse production as well as the ideal tDCS electrode placement for improving language at the discourse level. It is hypothesised that tDCS will result in greater language changes and improvements during discourse production compared to no stimulation.

Interventions

Transcranial direct-current stimulation is a non-invasive brain stimulation method that can modify spontaneous cortical activity in targeted brain regions. Anodal tDCS delivered through a positively charged electrode has been found to increase cortical excitability in a targeted brain region. Application of tDCS has been found to improve language production in healthy and brain-injured speakers.

Sponsors

King's College London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least 65 years of age * Native English speakers * Right handed * Normal aided or unaided visual acuity * At least secondary school level of education

Exclusion criteria

* History of neurological disease or cognitive impairment * Any contraindication of tDCS (i.e. history of seizures, metal implants)

Design outcomes

Primary

MeasureTime frameDescription
Change in utterance totalpre-intervention and immediately after the interventiontotal number of utterances (complete sentences including a predicate and argument) in a language sample
Change in word totalpre-intervention and immediately after the interventiontotal number of words in a language sample
Change in verb totalpre-intervention and immediately after the interventiontotal number of verbs in a language sample
Change in percent of Correct Information Unitspre-intervention and immediately after the interventionThe percent of accurately produced words that provide information relevant to the language task

Secondary

MeasureTime frameDescription
EPIC Physical Activity Questionnaire (EPAQ2)12 monthsThe EPAQ2 is a self completed questionnaire which collects information on a person's physical activity levels at home, work and recreation. Based on total activity hours in the last 12 months, the physical activity index categorises levels of physical activity into 'active', 'moderately inactive', 'moderately active' or 'active'.
The Keele Assessment of Participation (KAP)4 weeksThe KAP is a short questionnaire that measures participation levels in various activities such as activities of daily living, social activities and work in the last 4 weeks. A score of 0 indicates no restriction in participation whereas scores from 1-11 indicate a restriction in participation in at least one activity ( the higher the score the greater the restriction).
Hospital Anxiety and Depression Scale (HADS)7 daysHADS is a 14-item scale which assesses non-somatic anxiety and depression symptoms experienced in the past week. Scores range from 0 to 21 for each sub-scale with a score ≥8 proposed for the identification of caseness, for both depression and anxiety.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026